<section class="avModalContainer" id="popUpReferences">
    <!-- Ensure below ID matches with the ID provided in the shared component reference  --> 
    <div id="referenceContent">
        <div class="refTitle">References</div>
		<ul class="refContent lh21 fs17">
			<li>
			   	Rajasingham R, Enns EA, Khoruts A, Vaughn BP. Cost-effectiveness of treatment regimens for<br/>
				<span class="italic">Clostridium difficile</span> infectionâ€“an evaluation of the 2018 Infectious Diseases Society of America guidelines.<br/>
				[published online ahead of print April 17, 2019]. <span class="italic">Clin Infect Dis.</span> doi: 10.1093/cid/ciz318.
			</li>
			<li>
			  	Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for <span class="italic">Clostridium difficile</span> infection.<br/>
				<span class="italic">N Engl J Med.</span> 2011;364:422-31.
			</li>
			<li>
			   Cornely OA, Crook DW, Esposito R, et al. Fidaxomicin versus vancomycin for infection with <span class="italic">Clostridium</span><br/>
				<span class="italic">difficile</span> in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.<br/>
				<span class="italic">Lancet Infect Dis</span> 2012; 12(4): 281-9.
			</li>
			<li>
			   Openbiome.org. FMT preparation information. <a class="darkGray noDecoration" href="https://www.openbiome.org/treatment-information">https://www.openbiome.org/treatment-information.</a><br/>
				Accessed June 4, 2019.
			</li>
		</ul>
    </div> 
</section>